Explained: What’s at stake in India’s biggest ever trial of tuberculosis vaccines | Explained News, The Indian Express

Explained: What’s at stake in India’s biggest ever trial of tuberculosis vaccines | Explained News, The Indian Express
Written by Anuradha Mascarenhas |Pune |Updated: August 1, 2019 6:56:59 am

Explained: What’s at stake in India’s biggest ever trial of tuberculosis vaccines

Treating TB requires a multi-drug course of treatment lasting six months; longer still for treating drug-resistant TB. Treatment failure and recurrence can have devastating consequences.

India contributes to 27 per cent of the global TB burden; the highest share globally. (Source: File Photo)

On July 15, the Indian Council of Medical Research (ICMR) launched India’s first large-scale trial for two new tuberculosis (TB) vaccines.